- Home
- CREV vs CYCN Comparison
CREV vs CYCN Comparison
Compare CREV & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- CYCN
- Stock Information
- Founded
- CREV 2007
- CYCN 2018
- Country
- CREV Ireland
- CYCN United States
- Employees
- CREV N/A
- CYCN N/A
- Industry
- CREV
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- CYCN Health Care
- Exchange
- CREV Nasdaq
- CYCN Nasdaq
- Market Cap
- CREV 5.7M
- CYCN 6.5M
- IPO Year
- CREV N/A
- CYCN N/A
- Fundamental
- Price
- CREV $3.25
- CYCN $3.04
- Analyst Decision
- CREV
- CYCN
- Analyst Count
- CREV 0
- CYCN 0
- Target Price
- CREV N/A
- CYCN N/A
- AVG Volume (30 Days)
- CREV 417.9K
- CYCN 16.1K
- Earning Date
- CREV 05-14-2025
- CYCN 05-23-2025
- Dividend Yield
- CREV N/A
- CYCN N/A
- EPS Growth
- CREV N/A
- CYCN N/A
- EPS
- CREV N/A
- CYCN N/A
- Revenue
- CREV $39,261,077.00
- CYCN $2,081,000.00
- Revenue This Year
- CREV $40.76
- CYCN N/A
- Revenue Next Year
- CREV $86.18
- CYCN N/A
- P/E Ratio
- CREV N/A
- CYCN N/A
- Revenue Growth
- CREV 41.52
- CYCN N/A
- 52 Week Low
- CREV $2.00
- CYCN $1.27
- 52 Week High
- CREV $14.19
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- CREV 53.90
- CYCN 50.15
- Support Level
- CREV $2.64
- CYCN $2.83
- Resistance Level
- CREV $3.88
- CYCN $3.34
- Average True Range (ATR)
- CREV 0.50
- CYCN 0.32
- MACD
- CREV 0.02
- CYCN -0.04
- Stochastic Oscillator
- CREV 29.61
- CYCN 22.68
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.